US 11097011
Peptide oligonucleotide conjugates
granted A61KA61K38/00A61K47/18
Quick answer
US patent 11097011 (Peptide oligonucleotide conjugates) held by Sarepta Therapeutics, Inc. expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K47/18, A61K47/645, A61P